| 1 |
33430859 | Evaluation of cardiovascular risk factors in patients with familial hypercholesterolemia from the North-Eastern area of Romania. | 2021 Jan 11 |
1 |
| 2 |
27424313 | Vascular and metabolic effects of omega-3 fatty acids combined with fenofibrate in patients with hypertriglyceridemia. | 2016 Oct 15 |
2 |
| 3 |
27539098 | Hepatotoxic effects of fenofibrate in spontaneously hypertensive rats expressing human C-reactive protein. | 2016 Dec 13 |
1 |
| 4 |
22935083 | The effect of fenofibrate on lymphocyte release of proinflammatory cytokines and systemic inflammation in simvastatin-treated patients with atherosclerosis and early glucose metabolism disturbances. | 2013 Mar |
1 |
| 5 |
23236325 | Fenofibrate reduces C-reactive protein levels in hypertriglyceridemic patients with high risks for cardiovascular diseases. | 2012 Nov |
12 |
| 6 |
21117970 | Effects of coadministered ezetimibe plus fenofibrate in mixed dyslipidemic patients with metabolic syndrome. | 2011 Apr |
3 |
| 7 |
21276586 | Effect of simvastatin and fenofibrate on cytokine release and systemic inflammation in type 2 diabetes mellitus with mixed dyslipidemia. | 2011 Apr 1 |
1 |
| 8 |
21675801 | Fenofibrate: a review of its lipid-modifying effects in dyslipidemia and its vascular effects in type 2 diabetes mellitus. | 2011 Aug 1 |
1 |
| 9 |
21939559 | Short-term effect of fenofibrate on C-reactive protein: A meta-analysis of randomized controlled trials. | 2011 Sep 22 |
5 |
| 10 |
21942979 | Fenofibrate: a review of its use in dyslipidaemia. | 2011 Oct 1 |
1 |
| 11 |
20143119 | A comparative study of anti-inflammatory and antidyslipidemic effects of fenofibrate and statins on rheumatoid arthritis. | 2010 Jun |
1 |
| 12 |
19074515 | Impact of genetic and environmental factors on hsCRP concentrations and response to therapeutic agents. | 2009 Feb |
2 |
| 13 |
18285551 | Association of common C-reactive protein (CRP) gene polymorphisms with baseline plasma CRP levels and fenofibrate response: the GOLDN study. | 2008 May |
6 |
| 14 |
17209672 | Fenofibrate: a review of its use in primary dyslipidaemia, the metabolic syndrome and type 2 diabetes mellitus. | 2007 |
1 |
| 15 |
17522372 | Decrease in inflammatory cardiovascular risk markers in hyperlipidemic diabetic patients treated with fenofibrate. | 2007 Spring |
2 |
| 16 |
16810076 | Effects of fenofibrate on C-reactive protein levels in hypertriglyceridemic patients. | 2006 Jun |
5 |
| 17 |
16875159 | [The anti-inflammatory and antioxidants effects of micronized fenofibrate in patients with visceral obesity and dyslipidemia]. | 2006 May |
1 |
| 18 |
16990410 | Inhibitory effects of micronized fenofibrate on carotid atherosclerosis in patients with essential hypertension. | 2006 Nov |
1 |
| 19 |
15853856 | The effect of fenofibrate on the levels of high sensitivity C-reactive protein in dyslipidaemic hypertensive patients. | 2005 Apr |
1 |
| 20 |
16092057 | Targeting vascular risk in patients with metabolic syndrome but without diabetes. | 2005 Aug |
2 |
| 21 |
14764586 | Global suppression of IL-6-induced acute phase response gene expression after chronic in vivo treatment with the peroxisome proliferator-activated receptor-alpha activator fenofibrate. | 2004 Apr 16 |
2 |
| 22 |
15467191 | C-reactive protein-induced expression of CD40-CD40L and the effect of lovastatin and fenofibrate on it in human vascular endothelial cells. | 2004 Oct |
2 |
| 23 |
15543343 | Statin and fibrate treatment of combined hyperlipidemia: the effects on some novel risk factors. | 2004 Nov |
1 |
| 24 |
15554350 | The effect of fenofibrate on the levels of high sensitivity C-reactive protein in dyslipidemic obese patients. | 2004 Aug |
3 |
| 25 |
14612213 | Efficacy of fenofibrate and simvastatin on endothelial function and inflammatory markers in patients with combined hyperlipidemia: relations with baseline lipid profiles. | 2003 Oct |
1 |
| 26 |
11382718 | Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs. | 2001 May 29 |
1 |
| 27 |
9655393 | Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators. | 1998 Jun 25 |
1 |